Thermidas: A Breakthrough in Non-Invasive Skin Temperature Measurement

By HEOR Staff Writer

August 21, 2023

FinCCHTA, the Finnish Coordinating Centre for Health Technology Assessment, has recommended the use of Thermidas, a non-invasive thermal imaging system, to support diagnostics and monitor treatment. The system, which includes imaging analysis and reporting software, is particularly useful for measuring skin surface temperature changes.

Thermidas has been shown to be effective in monitoring temperature differences, indicating changes in the circulatory index, subclinical infections, the severity of vascular disease, and specific complications of Charcot neuro-osteoarthropathy. It has also been found to be a reliable and reproducible method for measuring temperature across areas, compared to traditional point-like temperature measurements in healthy adults.

The system has been particularly beneficial in the monitoring of diabetic foot ulcers and rheumatoid arthritis. A study demonstrated that infrared thermal imaging was able to detect temperature differences in the feet of a group of patients at high risk due to diabetes. Another cross-sectional study showed that combined thermal and ultrasound imaging provides better information about the area under examination than either imaging method used alone in assessing arthritis in rheumatoid arthritis cases.

The Thermidas system is recommended for use until April 2026. The manufacturer has provided evidence of theoretical cost savings, particularly in the monitoring of diabetic podiatric conditions and inflammatory rheumatoid arthritis, as well as in support of diagnostics. The purchase price of the system includes deployment training, with post-acquisition product and maintenance support subject to a fee. 

Reference url

Recent Posts

Biotechnology Act Europe
Biotechnology Act Europe Driving Innovation and Investment in Life Sciences

By João L. Carapinha

June 18, 2026

The Biotechnology Act Europe offers a once-in-a-generation chance to turn the continent’s world-class life sciences research into scalable commercial successes that remain in Europe rather than migrating elsewhere. By tackling regulatory fragmentation and sharpening investment signals, the legisl...
early-onset colorectal cancer
Rising Trends in Early-Onset Colorectal Cancer Burden

By João L. Carapinha

June 18, 2026

Early-onset colorectal cancer is rising sharply among adults under 50, even as overall colorectal cancer incidence and mortality have declined through improved prevention and treatment. Contemporary adults aged 30 to 40 now face higher risks at younger ages than their grandparents did, with the d...
FDA Importation Program Analysis
FDA Importation Program Analysis on Colorado’s Prescription Drug Initiative

By João L. Carapinha

June 18, 2026

This FDA Importation Program Analysis confirms that Colorado has secured a two-year authorization to import eligible prescription drugs under its Section 804 Importation Program (SIP), demonstrating that significant cost savings for American consumers are achievable without compromising safety or...